About Purine nucleoside phosphorylase
Purine nucleoside phosphorylase (PNP) is a protein
from Homo sapiens identified by UniProt accession
P00491, 289 residues long.
MolForge cross-references it against 0 known binders and
271 disease associations.
Target properties
| Protein name | Purine nucleoside phosphorylase |
| UniProt accession | P00491 |
| Gene | PNP |
| Organism | Homo sapiens |
| Length | 289 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (4)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (271)
Diseases linked to this target (Open Targets).
- purine nucleoside phosphorylase deficiency · score 0.80
- Combined immunodeficiency · score 0.46
- combined immunodeficiency · score 0.46
- T-B+ severe combined immunodeficiency · score 0.46
- severe combined immunodeficiency · score 0.46
- aspartate aminotransferase measurement · score 0.37
- serum alanine aminotransferase measurement · score 0.36
- blood protein measurement · score 0.34
- age at menopause · score 0.34
- mitochondrial DNA measurement · score 0.32
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P00491-F1 | alphafold | PREDICTED | 93.81 | — |
Amino-acid sequence (289 residues)
MENGYTYEDY KNTAEWLLSH TKHRPQVAII CGSGLGGLTD KLTQAQIFDY GEIPNFPRST VPGHAGRLVF GFLNGRACVM MQGRFHMYEG YPLWKVTFPV RVFHLLGVDT LVVTNAAGGL NPKFEVGDIM LIRDHINLPG FSGQNPLRGP NDERFGDRFP AMSDAYDRTM RQRALSTWKQ MGEQRELQEG TYVMVAGPSF ETVAECRVLQ KLGADAVGMS TVPEVIVARH CGLRVFGFSL ITNKVIMDYE SLEKANHEEV LAAGKQAAQK LEQFVSILMA SIPLPDKAS
Explore Purine nucleoside phosphorylase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets